Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Theravance Biopharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
121
+4 vs. Q4 2023
Shares held
48.0M
−822.2K (−1.7%) vs. Q4 2023
Total value
$430.6M
−$118.0M (−21.5%) vs. Q4 2023
New holders
19
36 more added
Sold out
15
46 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 121 institutions
Q1 2021: 107 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 116 institutionsQ1 2022: 121 institutionsQ2 2022: 113 institutionsQ3 2022: 123 institutionsQ4 2022: 119 institutionsQ1 2023: 114 institutionsQ2 2023: 119 institutionsQ3 2023: 115 institutionsQ4 2023: 118 institutionsQ1 2024: 121 institutionsQ2 2024: 132 institutionsQ3 2024: 119 institutionsQ4 2024: 128 institutionsQ1 2025: 132 institutionsQ2 2025: 135 institutionsQ3 2025: 161 institutionsQ4 2025: 169 institutionsQ1 2026: 173 institutionsQ2 2026: 179 institutions
Value heldQ1 2024: $430.6M
Q1 2021: $1.09BQ2 2021: $883.1MQ3 2021: $448.8MQ4 2021: $655.6MQ1 2022: $602.5MQ2 2022: $582.0MQ3 2022: $649.8MQ4 2022: $696.1MQ1 2023: $652.6MQ2 2023: $546.3MQ3 2023: $438.5MQ4 2023: $548.7MQ1 2024: $430.6MQ2 2024: $399.5MQ3 2024: $368.9MQ4 2024: $422.4MQ1 2025: $400.9MQ2 2025: $512.2MQ3 2025: $706.3MQ4 2025: $927.2MQ1 2026: $814.2MQ2 2026: $817.5M
Institutions holding TBPH and their total value by quarter
QuarterHoldersValue
Q2 2026179$817.5M
Q1 2026173$814.2M
Q4 2025169$927.2M
Q3 2025161$706.3M
Q2 2025135$512.2M
Q1 2025132$400.9M
Q4 2024128$422.4M
Q3 2024119$368.9M
Q2 2024132$399.5M
Q1 2024121$430.6M
Q4 2023118$548.7M
Q3 2023115$438.5M
Q2 2023119$546.3M
Q1 2023114$652.6M
Q4 2022119$696.1M
Q3 2022123$649.8M
Q2 2022113$582.0M
Q1 2022121$602.5M
Q4 2021116$655.6M
Q3 2021119$448.8M
Q2 2021109$883.1M
Q1 2021107$1.09B

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q4 2023.

Institutions holding TBPH in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Dimensional Fund Advisors LP238,502$2.14M0.00%+105,318+79.1%Added
Charles Schwab Investment Management Inc310,501$2.79M0.00%−3,510−1.1%Reduced
Wellington Management Group LLP330,962$2.97M0.00%+43,860+15.3%Added
Morgan Stanley419,113$3.76M0.00%+155,664+59.1%Added
Northern Trust Corp488,752$4.38M0.00%−33,184−6.4%Reduced
Bank of America Corp520,496$4.67M0.00%−42,038−7.5%Reduced
Jacobs Levy Equity Management, Inc557,971$5.00M0.02%+163,951+41.6%Added
D. E. Shaw & Co., Inc.781,585$7.01M0.01%−69,623−8.2%Reduced
Geode Capital Management, LLC967,452$8.68M0.00%−26,548−2.7%Reduced
Camber Capital Management LP1,000,000$8.97M0.31%+1,000,000New
Park West Asset Management LLC1,157,163$10.4M0.78%+257,163+28.6%Added
Oasis Management Co Ltd.1,157,965$10.4M3.70%+151,107+15.0%Added
State Street Corp1,368,781$12.3M0.00%−21,533−1.5%Reduced
Newtyn Management, LLC1,643,930$14.7M2.94%−256,070−13.5%Reduced
Pictet Asset Management Holding SA2,043,611$18.4M0.02%−124,786−5.8%Reduced
Vanguard Group Inc2,685,853$24.1M0.00%−803,409−23.0%Reduced
Irenic Capital Management LP2,760,948$24.8M6.34%00.0%Unchanged
BlackRock Inc.4,208,337$37.7M0.00%−379,497−8.3%Reduced
Baupost Group LLCSuperinvestorBaupost Group6,594,126$59.1M1.62%−825,100−11.1%Reduced
Madison Avenue Partners, LP7,012,226$62.9M10.15%00.0%Unchanged
Weiss Asset Management LP7,457,060$66.9M3.13%00.0%Unchanged
Highbridge Capital Management LLC0$00.00%−166,234−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−77,070−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−53,263−100.0%Sold out
Squarepoint Ops LLC0$00.00%−52,054−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−49,517−100.0%Sold out
Two Sigma Investments, LP0$00.00%−38,939−100.0%Sold out
Susquehanna Portfolio Strategies, LLC0$00.00%−13,317−100.0%Sold out
Bleakley Financial Group, LLC0$00.00%−12,584−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−10,100−100.0%Sold out
Natixis0$00.00%−2,000−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−441−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−280−100.0%Sold out
Allworth Financial LP0$00.00%−178−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−42−100.0%Sold out
JNBA Financial Advisors0$00.00%−1−100.0%Sold out
Sawtooth Solutions, LLC––––Not filed